Barclays aided CIPLAQCIL start manufacture of drugs.

Simple item page
dc.contributor.authorMutegeki, Geoffrey
dc.date.accessioned2026-06-09T21:50:28Z
dc.date.available2026-06-09T21:50:28Z
dc.date.issued2017-09-04
dc.descriptionNewspaper article
dc.description.abstractMalaria and HIV/AIDS are the leading causes of mortality and morbidity in Uganda at a rate 478 cases per 1,000 people and 230 registered new infections per day respectively. This is what inspired the proprietors of quality Chemicals industries Limited (CIPLAQCIL) to venture into manufacturing medicines that would positively change the situation.
dc.identifier.citationMutegeki, G. (2017). Barclays aided CIPLAQCIL start manufacture of drugs. New Vision.
dc.identifier.urihttps://bdears.busitema.ac.ug/handle/123456789/5149
dc.language.isoen
dc.publisherNew Vision
dc.titleBarclays aided CIPLAQCIL start manufacture of drugs.
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Geoffrey Mutegeki NV 4 Sept 2017.pdf
Size:
680.43 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Faculty of Health Sciences